Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
61,342,763
-
Share change
-
+99,427
-
Total reported value
-
$171,307,634
-
Put/Call ratio
-
18%
-
Price per share
-
$2.79
-
Number of holders
-
83
-
Value change
-
+$150,525
-
Number of buys
-
49
-
Number of sells
-
18
Institutional Holders of AVEO PHARMACEUTICALS INC - COM (AVEO) as of Q4 2017
As of 31 Dec 2017,
AVEO PHARMACEUTICALS INC - COM (AVEO) was held by
83 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,342,763 shares.
The largest 10 holders included
NEA Management Company, LLC, Polar Capital LLP, RA CAPITAL MANAGEMENT, LLC, Vanguard Group Inc, venBio Select Advisor LLC, PERCEPTIVE ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, 683 Capital Management, LLC, BlackRock Inc., and SPHERA FUNDS MANAGEMENT LTD..
This page lists
83
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.